Alleima (ALLEI) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
9 Jul, 2026Executive summary
Organic revenue growth was flat at 0% year-over-year, with revenues at SEK 5,359 million and improved market sentiment supported by a solid backlog.
Adjusted EBIT reached SEK 592 million with a margin of 11.1%, showing resilient earnings despite lower volumes; reported EBIT rose to SEK 689 million, aided by positive metal price effects.
Free operating cash flow surged to SEK 486 million from SEK 72 million year-over-year, reflecting strong liquidity and operational efficiency.
Market sentiment is improving, with previously weaker segments showing signs of recovery and strong backlog supporting future deliveries.
Strategic focus remains on profitable growth in less cyclical niches, sustainability-driven innovation, and operational improvements.
Financial highlights
Revenues were SEK 5,359 million, down 5% year-over-year, with organic growth at 0% compared to a record Q2 2023.
Adjusted EBIT was SEK 592 million (-8%), margin 11.1%; adjusted EPS rose to SEK 2.23, aided by positive finance net and lower tax rate.
Free operating cash flow was SEK 486 million, a strong result for Q2, partly due to catch-up from Q1.
Book-to-bill ratio at 102% on a rolling 12-month basis, indicating a solid backlog.
Net financial items were positive SEK 137 million, mainly from revaluation of financial instruments.
Outlook and guidance
Q3 2024 expected to see seasonally lower order intake, revenues, and adjusted EBIT margin, with product mix similar to Q2.
Cash flow is usually higher in the second half of the year; CapEx guidance for 2024 maintained at SEK 950 million.
Metal price effects expected to be negative SEK 50 million and currency effects negative SEK 15 million in Q3; tax rate guidance at 24%-26%.
Long-term targets include organic growth above end-market, adjusted EBIT margin above 9%, net debt/equity below 0.3x, and dividend ~50% of net profit.
Market sentiment is sequentially improving, with cautious optimism for the remainder of the year.
Latest events from Alleima
- Organic growth and record Kanthal margins achieved amid market uncertainty and strong liquidity.ALLEI
Q2 202617 Jul 2026 - Adjusted EBIT margin fell to 4.7% amid weak demand, FX headwinds, and restructuring actions.ALLEI
Q3 20259 Jul 2026 - Profitable growth, margin improvement, and sustainability drive expansion in high-value segments.ALLEI
CMD 20259 Jul 2026 - FY 2025 revenues reached SEK 18,630 million with an 8.3% EBIT margin amid market uncertainty.ALLEI
Company presentation1 Jun 2026 - Strong niche market positions, resilient earnings, and sustainability drive growth ambitions.ALLEI
Company presentation1 Jun 2026 - Order intake and revenues declined amid uncertainty, but key segments and balance sheet remained resilient.ALLEI
Q1 202627 Apr 2026 - Flat 2025 revenue, strong cash flow, and SEK 2.50 dividend amid FX and market headwinds.ALLEI
Q4 20252 Feb 2026 - Organic revenue up 3%, EBIT margin 7%, with strong nuclear and medical investments.ALLEI
Q3 202419 Jan 2026 - Stable earnings, strong cash, and growth in key segments despite mixed market demand.ALLEI
Q4 20249 Jan 2026